Samaritan Pharmaceuticals Announces Alzheimer Stem Cell Treatment
Related News: Spinal / Nervous / Brain, Stem Cell Companies, Stem Cell ResearchA new Alzheimer adult stem cell drug called SP-sc04 has being announced by stem cell research firm, Samaritan Pharmaceuticals Inc. (AMEX:LIV).
The goal of this new drug is to trigger normally dormant brain neuronal stem cells to differentiate into adult neuron cells.
Current preclinical trials are reportedly showing strong promise in this segment.
"We are extremely pleased with the progress and the potential of SP-04. Although it is early stage, each preclinical study we accomplish gives us hope that we might have an extraordinary treatment for the mind robbing disease of Alzheimer's," stated Dr. Greeson, CEO of Samaritan.
Posted on March 21, 2006 11:42 PM